Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age-Reference-Cited by-同舟云学术

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

Published:2017-12-14 Issue:2 Volume:14 Page:396-403
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Moreira E. D.¹,Giuliano A. R.²,de Hoon J.³,Iversen O.-E.⁴,Joura E. A.⁵,Restrepo J.⁶,Van Damme P.⁷,Vandermeulen C.⁸,Ellison M. C.⁹,Krick A.⁹,Shields C.⁹,Heiles B.⁹,Luxembourg A.⁹

Affiliation:

1. Centro de Pesquisa Clínica, Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador, Bahia, Brazil

2. Department of Cancer Epidemiology, Center for Infection Research (CIRC), Moffitt Cancer Center, Tampa, Florida, USA

3. Center for Clinical Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

4. Department of Clinical Science, University of Bergen/Womens Clinic, Haukeland University Hospital, Bergen, Norway

5. Department of Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

6. Fundación Centro de Investigación Clínica CIC, Medellín, Colombia

7. University of Antwerp, Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, Antwerp, Belgium

8. Leuven University Vaccinology Center, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

9. Merck & Co. Inc., Kenilworth, New Jersey, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1403700

Reference23 articles.

1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

2. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV

3. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

4. Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

5. Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión rápida: vacunación contra el virus del papiloma humano en niños y hombres;Revista Salud Bosque;2024-06-07

2. Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China;Expert Review of Vaccines;2023-07-27

3. Awareness and Attitude of Polish Gynecologists and General Practitioners towards Human Papillomavirus Vaccinations;Healthcare;2023-04-10

4. HPV vaccination programs in LMIC: is it time to optimize schedules and recommendations?;Jornal de Pediatria;2023-03

5. Evaluation of Polish Adolescents' Knowledge About Human Papillomavirus and Vaccines;Journal of Adolescent and Young Adult Oncology;2022-11-15